C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option

Economic and political factors have led to the increased use of home therapy programmes for patients who have traditionally been treated in hospital. Many patients with hereditary angioedema (HAE) experience intermittent severe attacks that affect their quality of life and may be life-threatening. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Longhurst, H J, Carr, S, Khair, K
Formato: Texto
Lenguaje:English
Publicado: Blackwell Science Inc 2007
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804208/
https://www.ncbi.nlm.nih.gov/pubmed/17177958
http://dx.doi.org/10.1111/j.1365-2249.2006.03256.x
_version_ 1782132441366921216
author Longhurst, H J
Carr, S
Khair, K
author_facet Longhurst, H J
Carr, S
Khair, K
author_sort Longhurst, H J
collection PubMed
description Economic and political factors have led to the increased use of home therapy programmes for patients who have traditionally been treated in hospital. Many patients with hereditary angioedema (HAE) experience intermittent severe attacks that affect their quality of life and may be life-threatening. These attacks are treated with C1-inhibitor concentrate which, for most patients, is infused at the local hospital. Home therapy programmes for HAE are currently being established. This paper reviews the extent of use of these programmes and summarizes the advantages and potential disadvantages of the concept so far.
format Text
id pubmed-1804208
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Blackwell Science Inc
record_format MEDLINE/PubMed
spelling pubmed-18042082008-01-01 C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option Longhurst, H J Carr, S Khair, K Clin Exp Immunol Review Articles Economic and political factors have led to the increased use of home therapy programmes for patients who have traditionally been treated in hospital. Many patients with hereditary angioedema (HAE) experience intermittent severe attacks that affect their quality of life and may be life-threatening. These attacks are treated with C1-inhibitor concentrate which, for most patients, is infused at the local hospital. Home therapy programmes for HAE are currently being established. This paper reviews the extent of use of these programmes and summarizes the advantages and potential disadvantages of the concept so far. Blackwell Science Inc 2007-01 /pmc/articles/PMC1804208/ /pubmed/17177958 http://dx.doi.org/10.1111/j.1365-2249.2006.03256.x Text en © 2006 The Author(s); Journal compilation © 2006 British Society for Immunology https://creativecommons.org/licenses/by-nc/2.5/Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Review Articles
Longhurst, H J
Carr, S
Khair, K
C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option
title C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option
title_full C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option
title_fullStr C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option
title_full_unstemmed C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option
title_short C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option
title_sort c1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804208/
https://www.ncbi.nlm.nih.gov/pubmed/17177958
http://dx.doi.org/10.1111/j.1365-2249.2006.03256.x
work_keys_str_mv AT longhursthj c1inhibitorconcentratehometherapyforhereditaryangioedemaaviableeffectivetreatmentoption
AT carrs c1inhibitorconcentratehometherapyforhereditaryangioedemaaviableeffectivetreatmentoption
AT khairk c1inhibitorconcentratehometherapyforhereditaryangioedemaaviableeffectivetreatmentoption

Ejemplares similares